Read More

Amryt Secures UK Regulatory Nod And Orphan Disease Status For Skin Disorder Candidate

The Medical Healthcare & Products Regulatory Agency (MHRA) has granted Marketing Authorisation Approval (MAA) and Orphan Disease Designation (ODD) for Amryt’s (NASDAQ: AMYT) lead candidate Filsuvez for the treatment of partial thickness wounds associated with dystrophic and junctional Epidermolysis Bullosa (EB) in

AMYT

Read More

US Stocks Could Lose Momentum Thursday As Futures Trade Flat Ahead Of Powell Speech — Tesla, GameStop In Focus

The major U.S. index futures are little changed on Thursday, as apprehensions return after Wednesday’s strong advances. Investors are left to contend with more Fed speeches, while the corporate news flow remains fairly light. On Wednesday, U.S. stocks opened mostly higher and stayed above the unchanged line for the bulk of the session, before closing notably higher.

BILI